Schulman Amy W
- SEC CIK
- 0001438226
In the past year, 1 open-market sale filing worth $7.47K and no purchases.
Current role at each company
- ALNY Alnylam Pharmaceuticals, Inc.Directoras of May 22, 2026
- ELV Elevance Health, Inc.Directoras of May 15, 2026
- CAMP Camp4 Therapeutics Corp10% Owneras of Sep 11, 2025
- GUTS Fractyl Health, Inc.Directoras of Jun 13, 2025
- SQZ SQZ Biotechnologies CoDirector, 10% Owneras of Jun 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.47K
- 1 filing
- Net
- −$7.47K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Schulman Amy W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ELV Elevance Health, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 (view filing) | Mar 12 | 11 daysLate | Schulman Amy WDirector | SSale | −26 | $287.50 | −$7.47K | −10.7%218 after |
CAMP Camp4 Therapeutics Corp
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 (view filing)4:59 PM ET | Sep 11 | Same day | Chee Brian and 6 others10% Owner | PPurchase | +1.31M | $1.53 | +$2.00M | New position197.7K after | 2 lotsDuplicate filing |
| Oct 22, 2024 (view filing)5:31 PM ET | Oct 15 | 7 days | Chee Brian and 6 others10% Owner | PPurchase | +909.1K | $11.00 | +$10.0M | New position909.1K after | AmendedDuplicate filing |
| Oct 15, 2024 (view filing)6:00 PM ET | Oct 15 | Same day | Schulman Amy W and 5 others10% Owner | PPurchase | +909.1K | $11.00 | +$10.0M | New position909.1K after | Duplicate filing |
GUTS Fractyl Health, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 (view filing) | Mar 13 | 4 days | Schulman Amy WDirector | PPurchase | +8.55K | $1.17 | +$10.0K | New position8.55K after |
ALNY Alnylam Pharmaceuticals, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2024 (view filing) | Jun 25 | 2 days | Schulman Amy WDirector | SSale | −8.50K | $240.00 | −$2.04M | −50.2%8.44K after | 10b5-1 |
| May 31, 2024 (view filing) | May 29 | 2 days | Schulman Amy WDirector | SSale | −21.7K | $148.60 | −$3.22M | −72.0%8.44K after | 3 lots10b5-1 |
SQZ SQZ Biotechnologies Co
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 (view filing) | Dec 13 | 2 days | Schulman Amy WDirector, 10% Owner | PPurchase | +3.70K | $10.91 | +$40.4K | New position1.85K after | 2 lots |